This Taser Maker's Stock Falls 19% After Record Revenue. Here's Why. -- Barrons.com

Dow Jones
2025/11/05

By Nate Wolf

Shares of Axon Enterprise plummeted Wednesday after the maker of tasers and software for law enforcement posted weaker-than-expected earnings even as it recorded record revenue.

Axon reported adjusted earnings of $1.17 a share for the third quarter, well below analysts' consensus calls for $1.52. Revenue totaled $711 million, up 31% from last year and narrowly ahead of Wall Street's call for $705 million. The figure marked a record high for Axon and a seventh consecutive quarter of revenue growth above 30%.

Axon stock was down 19% on Wednesday. It was the worst performer in the S&P 500 in the premarket session.

While revenue keeps going up, so too do costs. Axon reported an operating loss of $2.2 million, down from a profit of $67 million last year. The loss was driven primarily by increased headcount and stock-based compensation expense, Axon said. The company has reported four straight quarters of operating losses.

Axon forecast fourth-quarter revenue of between $750 million and $755 million, representing approximately 31% year-over-year growth, which is in line with analysts' expectations. Adjusted earnings before interest, taxes, depreciation, and amortization are expected to total $178 million to $182 million, below the $187 million Wall Street had anticipated.

The company is still making investments amid the rising costs, though. On Tuesday, Axon announced an agreement to acquire Carbyne, a privately held emergency communications platform. The deal values Carbyne at $625 million and is expected to close in the first quarter of 2026.

Write to Nate Wolf at nate.wolf@barrons.com

This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

November 05, 2025 08:43 ET (13:43 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10